William F. Trager
Affiliations: | 1967-1972 | Pharmacy | University of California, San Francisco, San Francisco, CA |
1972-2009 | University of Washington, Seattle, Seattle, WA |
Area:
BiochemistryWebsite:
https://sop.washington.edu/william-f-trager-ph-d-remembrance/Google:
"William Frank Trager"Bio:
(1937 - 2009)
Mean distance: (not calculated yet)
Parents
Sign in to add mentorAlain C. Huitric | grad student | 1965 | University of Washington | |
(NMR analysis of substituted cyclohexylamine and nitrocyclohexanes; strong coupling and solvent effects in conformational analysis of mobile six-membered ring compounds.) | ||||
Arnold Heyworth Beckett | post-doc | 1967 | University of London |
Children
Sign in to add traineeSidney D. Nelson | grad student | 1974 | UCSF |
Ronald G. Aoyama | grad student | 2003 | University of Washington |
Michael J. Trnka | grad student | 2004 | University of Washington |
Allan E. Rettie | post-doc | 1987 | University of Washington |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Trnka MJ, Doneanu CE, Trager WF. (2006) Photoaffinity labeling of P450Cam by an imidazole-tethered benzophenone probe. Archives of Biochemistry and Biophysics. 445: 95-107 |
Suzuki H, Kneller MB, Rock DA, et al. (2004) Active-site characteristics of CYP2C19 and CYP2C9 probed with hydantoin and barbiturate inhibitors. Archives of Biochemistry and Biophysics. 429: 1-15 |
Nelson SD, Trager WF. (2003) The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 31: 1481-98 |
Lightning LK, Trager WF. (2002) Characterization of covalent adducts to intact cytochrome P450s by mass spectrometry. Methods in Enzymology. 357: 296-300 |
Suzuki H, Kneller MB, Haining RL, et al. (2002) (+)-N-3-Benzyl-nirvanol and (-)-N-3-benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 235-9 |
Henne KR, Fisher MB, Iyer KR, et al. (2001) Active site characteristics of CYP4B1 probed with aromatic ligands. Biochemistry. 40: 8597-605 |
He M, Rettie AE, Neal J, et al. (2001) Metabolism of sulfinpyrazone sulfide and sulfinpyrazone by human liver microsomes and cDNA-expressed cytochrome P450s. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 29: 701-11 |
Rao S, Aoyama R, Schrag M, et al. (2000) A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions. Journal of Medicinal Chemistry. 43: 2789-96 |
Lightning LK, Jones JP, Friedberg T, et al. (2000) Mechanism-based inactivation of cytochrome P450 3A4 by L-754,394. Biochemistry. 39: 4276-87 |
He M, Korzekwa KR, Jones JP, et al. (1999) Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9. Archives of Biochemistry and Biophysics. 372: 16-28 |